Congress mandates free blood pressure monitors for pregnant women

What it does

This bill requires Medicaid, CHIP, and private health insurance plans to cover self-measured blood pressure monitoring devices for pregnant and postpartum individuals (up to 12 months after delivery) at no cost to the patient. The device must be FDA-cleared and validated by the American Medical Association. Each person can receive one device per 2-year period. The bill aims to help detect pregnancy-related hypertension and preeclampsia early.

Why we flagged it

The bill's core function is to require insurers to cover a specific preventive device for a defined population (pregnant/postpartum individuals) to address a documented maternal health risk. It is a public-health mandate, not a tax provision, subsidy, or deregulation.

What the text implies

• Device manufacturers (particularly those with AMA-validated products) may see increased demand and market capture, though the bill does not name or favor specific manufacturers.
• States with Medicaid plans may face administrative and fiscal burden to implement coverage within 120 days; the bill includes a grace period for states requiring legislative action.
• The 'specified blood pressure management device' definition ties validation to the American Medical Association's Validated Device Listing, potentially creating a gatekeeping role for AMA and limiting device competition.
• Postpartum coverage extends 12 months after delivery (or longer for Medicaid-eligible individuals), which is broader than typical postpartum benefit windows and may increase overall insurance costs.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Pregnant and postpartum individuals gain access to a validated preventive health tool at no out-of-pocket cost, addressing a documented public health gap (pregnancy-related hypertension and preeclampsia are leading causes of maternal mortality). The mandate applies uniformly across Medicaid, CHIP, and private insurance, ensuring broad coverage without cost-sharing barriers.

Who stands to gain

• manufacturers of FDA-cleared, AMA-validated blood pressure monitoring devices
• medical device distributors and suppliers

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Medicaid, CHIP (Children's Health Insurance Program), American Medical Association (AMA), FDA (Food and Drug Administration), Private health insurers, Group health plans, ERISA (Employee Retirement Income Security Act)

Where it stands

6 cosponsors: 6 Democrats.

• May 7, 2026 — Introduced · Congress.gov: “Introduced in House”
• May 7, 2026 — Referred to House Committee on Education and Workforce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.